Thromboelastography (TEG) and ROTEM provide a real-time, global view of how blood clots—from initiation through strengthening to dissolution—form and break down in whole blood. This dynamic information lets clinicians tailor transfusion and hemostatic therapy to the patient’s actual coagulation status. By watching initiation (how quickly the clot starts), formation and strength (how robust the clot becomes), and lysis (how much it breaks down), you can decide whether to target platelets, fibrinogen (or cryoprecipitate), plasma factors, or antifibrinolytic therapy. This contrasts with tests that measure a single aspect, such as platelet count, D-dimer, or a specific factor level, which don’t capture the integrated, functioning clot in real time. In practice, TEG/ROTEM guides transfusion decisions and coagulopathy management across settings like trauma, major surgery, liver disease, and obstetrics by providing a practical picture of how the clot behaves under physiological conditions.

Fibrinogen testing uses two complementary approaches to capture different aspects of the protein’s role in clot formation. The functional assessment, typically done with the Clauss method, measures how well fibrinogen can support a clot. It does this by triggering polymerization with an excess of thrombin and recording the time to clot formation. This functional readout is particularly useful for detecting qualitative defects in fibrinogen, such as dysfibrinogenemia, where the amount may be normal but the function is impaired. The antigen, or immunologic, assay quantifies how much fibrinogen protein is present in the plasma. It tells you the concentration, independent of whether the molecule is functioning properly. This is important for identifying true shortages of fibrinogen (hypofibrinogenemia) or monitoring replacement therapy, but it does not directly assess functional activity. In practice, both tests are used because patients can have discordant results—normal fibrinogen levels with impaired function, or low levels with preserved function. Relying on only one approach could miss clinically relevant abnormalities. The other statements aren’t accurate: fibrinogen testing is indeed used in evaluating coagulopathy, and it is not a platelet function test.

Thrombin time measures the last step of coagulation: the conversion of fibrinogen into fibrin by thrombin. If this step is delayed, it points to problems with the fibrinogen itself or with thrombin activity. Dysfibrinogenemia means the fibrinogen molecule is defective and cannot be converted efficiently to fibrin, while low fibrinogen levels reduce substrate availability for thrombin; both prolong the thrombin time. Also, any thrombin inhibitor in the blood (such as heparin or a direct thrombin inhibitor) slows the action of thrombin, prolonging the thrombin time. Defects in factor VII or factor XII affect earlier pathways (extrinsic and intrinsic pathways) and typically alter prothrombin time or partial thromboplastin time, not the thrombin time. Deficiency of vitamin K–dependent factors disrupts initiation and amplification of coagulation and also tends to prolong PT/aPTT rather than the final fibrinogen-to-fibrin conversion, unless there’s an additional fibrinogen issue. Hence, a prolonged thrombin time most specifically points to a problem with fibrinogen function or the presence of thrombin inhibitors.

Platelet count in SI units is expressed as the number of platelets per liter (per liter is the SI base for such counts). The normal way to write this is in billions per liter, i.e., ×10^9/L. So a count of 178 × 10^9/L means about 178 billion platelets per liter, which fits the typical adult reference range of roughly 150–450 × 10^9/L (equivalent to about 150,000–450,000 platelets per microliter). The other formats don’t align with SI conventions or the usual magnitudes: using ×10^3/L would give 178,000 per liter, far too low; expressing per cubic millimeter with ×10^9 would misstate the scale (1 μL = 1 mm^3, so the typical per-μL value would be about ×10^3/μL, not ×10^9/μL); and an enormous figure like 712,000 × 10^9/L is not plausible for a human blood count.